# A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I

> clinical trial · VERIFIED · 2026-06-08

Status: NOT_YET_RECRUITING · Sponsor: Lanyue Biotech (Hangzhou) Co., Ltd. · Condition: Spinal Muscular Atrophy 1

- Company: Lanyue Biotech (Hangzhou) Co., Ltd.
- Sector: rare disease
- Primary source: https://clinicaltrials.gov/study/NCT07554924

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.